01
Cash & equivalents increased 14.1%
Cash & equivalents changed +14.1% from the comparable as-filed period.
$17.0M→$19.4MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTNeuphoria Therapeutics Inc.'s latest supported as-filed period reports revenue of $15.6M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +14.1% from the comparable as-filed period.
Net income changed -104.5% from the comparable as-filed period.
Operating income changed -110.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Each point keeps the date investors could first observe it and its accession.
NEUP · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001213900-26-081052SEC ↗8-KMay 26, 2026Period May 21, 20260001213900-26-061028SEC ↗10-QMay 15, 2026Period Mar 31, 20260001193125-26-225442SEC ↗10-QFeb 17, 2026Period Dec 31, 20250001193125-26-054509SEC ↗4Jan 21, 2026Period Jan 20, 20260001213900-26-006173SEC ↗4Jan 21, 2026Period Jan 20, 20260001213900-26-006171SEC ↗4Jan 21, 2026Period Jan 20, 20260001213900-26-006172SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jan 20, 2026Filed Jan 21, 2026 | Wilson David IanDirector | Grant Or AwardDirect | 8,537 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001213900-26-006170